Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v2-FR
Language French French
Date Updated 2022-10-15 2022-04-26
Drug Identification Number 02375516 02375516
Brand name ZOSTAVAX II ZOSTAVAX II
Common or Proper name (zoster vaccine live, attenuated [Oka/Merck], refrigerator-stable) powder for suspension for injection (zoster vaccine live, attenuated [Oka/Merck], refrigerator-stable) powder for suspension for injection
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED
Strength(s) 19400PFU 19400PFU
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1 dose vial 1 dose vial
ATC code J07BK J07BK
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2022-10-14 2022-11-03
Actual discontinuation date 2022-10-14
Remaining supply date 2022-10-14 2022-11-03
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments